Lymphoma Immunotherapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers in New York are doing work on developing cancer vaccines.

Cancer vaccine helped keep melanoma under control for years in small study Nicoletta Lanese © Provided by Live Science T cells attacking cancer cell A personalized "cancer vaccine" may help keep a deadly form of skin cancer from growing for years, a small new study in humans suggests. Unlike vaccines that prevent infections, such as measles and influenza, cancer vaccines are a form of immunotherapy that take down cancer cells that already exist. The vaccines train immune cells, called T cells, to better recognize cancer and target it for destruction, while sparing healthy c...

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at? The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the researchers reported in a study published in Cancer Discovery in December. Cancer immunotherapies target antigens, or proteins, on the surface of tumor cel...

 E-Mail New York, NY (December 17, 2020) -- Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at? The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the researchers reported in a study published in Cancer Discovery in December. Cancer immunotherapies target antigens, or proteins, on the surface of tumor cells. One common example is a protein ca...